ASTRAZENECA PLC (AZNCF)
Clinical trial NCT05261399 updates: 1. primary completion date: 2026-06-18 → 2026-07-06 2. enrollment: 345 → 341 participants
Clinical trial NCT05261399 updates: 1. primary completion date: 2026-06-18 → 2026-07-06 2. enrollment: 345 → 341 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical